Group Leader & Professor
P: +91 80 2750 6270
E: rohidas.arote@jainuniversity.ac.in
Research Interests
The Nanomedicine Laboratory pursues cutting-edge research at the convergence of gene therapy, drug delivery, biomaterials, biomedical engineering, and theranostics, with a core mission to develop clinically translatable nanotechnologies for precision medicine. The lab’s primary research thrust centers on the design of advanced non-viral gene delivery systems for targeted cancer therapy, emphasizing safety, efficiency, and tumor-specific targeting.
A major focus is placed on developing and engineering of biodegradable polymeric nanocarriers for highly efficient nucleic acid and drug delivery, enabling controlled release, enhanced cellular uptake, and superior transfection performance for applications in cancer treatment, immune modulation, and regenerative medicine. The lab also advances nanotechnology-enabled drug delivery strategies to improve the bioavailability, pharmacokinetics, and therapeutic index of small molecules and biologics.
The Nanomedicine lab actively explores nanotechnology-driven drug delivery platforms to enhance drug bioavailability, therapeutic efficacy, and safety while minimizing systemic toxicity. Parallel efforts are directed toward the development of biocompatible and functional biomaterials for tissue engineering and regenerative therapies, contributing to the creation of next-generation medical implants and scaffolds.
Through its interdisciplinary approach, the Nanomedicine Lab integrates pharmaceutics, materials science, pharmaceutical sciences, and theranostics to address fundamental challenges in disease treatment and translational medicine. With strong international collaborations, the lab continues to pioneer theranostic nanoplatforms that unify diagnosis and therapy, accelerating the translation of nanomedicine from bench to bedside.
|
